SCHEMBL44646

SCHEMBL44646

CCc1cc(CCN)ccc1Cl

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 1/20 0.62
TAAR1 Q96RJ0 8/20 0.62
PNMT P11086 1/20 0.62
GLA P06280 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
SIGMAR1 Q99720 2/20 0.43
KDM4E B2RXH2 2/20 0.43
ATM Q13315 1/20 0.43
CSNK2A2 P19784 1/20 0.42
CSNK2B P67870 1/20 0.42
CSNK2A1 P68400 1/20 0.42
CSNK2A3 Q8NEV1 1/20 0.42
ALDH1A1 P00352 1/20 0.42
TP53 P04637 1/20 0.42
ADRB2 P07550 1/20 0.42
HTR1A P08908 1/20 0.42
ADRA2A P08913 1/20 0.42
CYP2D6 P10635 1/20 0.42
MAPT P10636 1/20 0.42
DRD2 P14416 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL44146 0.98 BACE1 (0.61) BACE1TAAR1PNMTGLASMN1; SMN2
SCHEMBL12075684 0.87 BACE1 (0.49) BACE1TAAR1PNMTGLASMN1; SMN2
SCHEMBL10509791 0.85 TAAR1 (0.52) BACE1TAAR1PNMTGLASMN1; SMN2
SCHEMBL5847395 0.84 CSNK2A1 (0.57) BACE1TAAR1PNMTCSNK2A2CSNK2B
SCHEMBL3847706 0.82 BACE1 (0.69) BACE1TAAR1PNMTGLAKDM4E
SCHEMBL3790563 0.81 TRPA1 (0.43) BACE1SMN1; SMN2SIGMAR1KDM4ECSNK2A2
SCHEMBL15471848 0.81 TAAR1 (0.62) BACE1TAAR1PNMTSIGMAR1KDM4E
SCHEMBL44421 0.79 ALDH1A1 (0.44) BACE1TAAR1PNMTKDM4EALDH1A1
SCHEMBL15787347 0.78 BACE1 (0.42) BACE1SIGMAR1KDM4EALDH1A1ALOX15
SCHEMBL91283 0.78 GPR84 (0.44) BACE1TAAR1PNMTGLASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011157670-A2 NOVEL PROCESS F. HOFFMANN-LA ROCHE AG (CH) 2011-12-22 WO disclosed
WO-2011157670-A2 NOVEL PROCESS F. HOFFMANN-LA ROCHE AG (CH) 2011-12-22 WO disclosed
US-20110313196-A1 NOVEL PROCESS HOFFMANN-LA ROCHE, INC. 2011-12-22 US disclosed
US-20110313196-A1 NOVEL PROCESS HOFFMANN-LA ROCHE, INC. 2011-12-22 US disclosed
US-20110313196-A1 NOVEL PROCESS HOFFMANN-LA ROCHE, INC. 2011-12-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110313196-A1 NOVEL PROCESS CYP3A5, CYP3A4, GBA1 BACE1 1928/4885TAAR1 3928/4885PNMT 1173/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.